Financials

  • Market Capitalization 16.48 M
  • Employee 29
  • Founded 1986
  • CEO Carl Spana
  • Website www.palatin.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BN9PY4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
4.79
Rapporto prezzo/fatturato
1.91

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4685
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.73 USD-2.61%+7.18%+18.41%+17.30%16.15 M USD
4693
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.49 USD+2.08%-2.00%-9.26%-25.76%16.37 M USD
4699
HIND
Vyome Holdings, Inc. - Common Stock
2.24 USD+2.75%+6.16%+1.82%-84.29%15.72 M USD
4705
TPST
Tempest Therapeutics, Inc. - Common Stock
1.06 USD+8.16%+6.00%-15.20%-55.65%15.70 M USD

Notizie